Clinical Trials Browser

Phase 2 × Ranibizumab × Dermatologic × Clear all

NCT01251978 2016-10-19

Ranibizumab as Adjuvant Therapy for the Treatment of Choroidal Melanoma (Cohort 2)

Phase 2 Completed

10 enrolled 7 charts

Uveal Melanoma